Fonar Corp (FONR)
15.80
-0.19
(-1.19%)
USD |
NASDAQ |
Dec 09, 13:54
Fonar Price to Book Value: 0.5994 for Dec. 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
December 06, 2024 | 0.6066 |
December 05, 2024 | 0.6009 |
December 04, 2024 | 0.6165 |
December 03, 2024 | 0.6104 |
December 02, 2024 | 0.6096 |
November 29, 2024 | 0.6248 |
November 27, 2024 | 0.6218 |
November 26, 2024 | 0.624 |
November 25, 2024 | 0.6229 |
November 22, 2024 | 0.6237 |
November 21, 2024 | 0.624 |
November 20, 2024 | 0.5649 |
November 19, 2024 | 0.5599 |
November 18, 2024 | 0.5641 |
November 15, 2024 | 0.5702 |
November 14, 2024 | 0.5876 |
November 13, 2024 | 0.5963 |
November 12, 2024 | 0.5857 |
November 11, 2024 | 0.5664 |
November 08, 2024 | 0.5702 |
November 07, 2024 | 0.5769 |
November 06, 2024 | 0.5853 |
November 05, 2024 | 0.5902 |
November 04, 2024 | 0.5548 |
November 01, 2024 | 0.5819 |
Date | Value |
---|---|
October 31, 2024 | 0.5796 |
October 30, 2024 | 0.5906 |
October 29, 2024 | 0.5834 |
October 28, 2024 | 0.5868 |
October 25, 2024 | 0.5803 |
October 24, 2024 | 0.5857 |
October 23, 2024 | 0.5922 |
October 22, 2024 | 0.5891 |
October 21, 2024 | 0.5883 |
October 18, 2024 | 0.5983 |
October 17, 2024 | 0.5975 |
October 16, 2024 | 0.5887 |
October 15, 2024 | 0.5963 |
October 14, 2024 | 0.5861 |
October 11, 2024 | 0.5796 |
October 10, 2024 | 0.5914 |
October 09, 2024 | 0.6024 |
October 08, 2024 | 0.6044 |
October 07, 2024 | 0.6124 |
October 04, 2024 | 0.6177 |
October 03, 2024 | 0.6063 |
October 02, 2024 | 0.604 |
October 01, 2024 | 0.6044 |
September 30, 2024 | 0.6173 |
September 27, 2024 | 0.6811 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5106
Minimum
Oct 25 2023
1.380
Maximum
Aug 11 2020
0.8129
Average
0.7702
Median
Feb 24 2022
Price to Book Value Benchmarks
XWELL Inc | 1.234 |
ProPhase Labs Inc | 0.4534 |
Applied DNA Sciences Inc | 0.1730 |
Veracyte Inc | 2.800 |
OncoCyte Corp | 4.317 |
Price to Book Value Related Metrics
PE Ratio | 11.29 |
PS Ratio | 0.9975 |
Price to Free Cash Flow | 9.626 |
Price | 15.80 |
Earnings Yield | 8.86% |
Market Cap | 101.11M |
Operating PE Ratio | 6.983 |
Normalized PE Ratio | 14.15 |